Connect with us

Health

Studies find no COVID benefit for preventive hydroxychloroquine or for convalescent plasma – CIDRAP

“There are no compelling data to suggest that hydroxychloroquine is effective.”

Published

on

post featured image

Two studies published yesterday in the New England Journal of Medicine found that two once-promising but largely discredited COVID-19 treatmentshydroxychloroquine and convalescent plasmadidn’t prevent infection or lead to clinical improvement.
‘No compelling data’
The first study, an open-label trial led by researchers at Hospital Germans Trias i Pujol in Barcelona, Spain, involved randomly assigning clusters of healthy adults with high-risk, close-contact exposure to a COVID-19 patient to either…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending